英国药品监管机构负责人周二表示，基于人工智能的医疗设备即使在获批使用后也需要持续监测，而不是仅进行一次性批准前安全检查。
AI-based medical devices will need constant monitoring even after they're approved for use, rather than a single pre-approval safety check, the head of the UK's medicines regulator said on Tuesday.